By indication / Radiochemistry methodology
Radiochemistry methodology
18 imaging agents and 10 therapeutic agents reported for this indication. Stage reflects how far each has been taken, not what is available in any given country.
Imaging
| Agent | Isotope | Stage | Runs |
|---|---|---|---|
| [18F]DAA1106 | F-18 | Preclinical | 4 |
| [18F]FTHA | F-18 | — | 4 |
| [18F]FBEM | F-18 | Research | 3 |
| [11C]L-glutamine | C-11 | — | 2 |
| [18F]PBR102 | F-18 | Preclinical | 2 |
| [68Ga]Ga-FAP-2286 paired with [177Lu]Lu-FAP-2286 | Ga-68 | — | 2 |
| [89Zr]ZrCl4 | Zr-89 | Clinical research | 2 |
| [18F]FBAM | F-18 | Preclinical | 1 |
| [18F]FCPPC | F-18 | — | 1 |
| [18F]JNJ-46356479 | F-18 | — | 1 |
| [18F]MEL050 | F-18 | Clinical research | 1 |
| [18F]NS10743 | F-18 | Preclinical | 1 |
| [18F](E)-PSS232 | F-18 | — | 1 |
| [68Ga]Ga-3p-C-NETA paired with [161Tb]Tb-3p-C-NETA | Ga-68 | Preclinical | 1 |
| [18F]RSO2CF2H | F-18 | Research | |
| [11C]phosgene | C-11 | — | |
| [18F]FDR | F-18 | Preclinical | |
| [18F]fluoroethylazide | F-18 | — |
Therapy
| Agent | Isotope | Stage | Runs |
|---|---|---|---|
| [177Lu]Lu-DOTA-TOC paired with [68Ga]Ga-DOTA-TOC | Lu-177 | — | 11 |
| [211At]At-MABG | At-211 | Preclinical | 6 |
| [225Ac]Ac-PSMA-I&T paired with [68Ga]Ga-PSMA-I&T | Ac-225 | Clinical research | 4 |
| [177Lu]Lu-CTT2001 | Lu-177 | Clinical research | 2 |
| [188Re]Re-MAG3 | Re-188 | — | 2 |
| [161Tb]Tb-TbCl3 | Tb-161 | Preclinical | 2 |
| [188Re]Re-188-HYNIC-BBN | Re-188 | Preclinical | 1 |
| [188Re]Re-tricarbonyl(cyclopentadienylcarbonate)rhenium | Re-188 | Preclinical | 1 |
| [188Re]Re-CpTR-COOH | Re-188 | — | |
| [211At]At-astatophenethylsuccinamate | At-211 | Preclinical |
Other entries
| Agent | Isotope | Stage | Runs |
|---|---|---|---|
| [18F]Albumin | F-18 | — | 1 |
| [68Ga]Ga-MAA | Ga-68 | — | 1 |
| [140Nd]Nd-DOTA | Nd-140 | Preclinical | |
| [213Bi]Bi3+ | Bi-213 | — |
Have a question?Reagents, modules, introductions to manufacturers or to specialists in your region - tell us what you need.
Get in touch